These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3298085)

  • 1. In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.
    Webb G; Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Int J Clin Pharmacol Res; 1987; 7(3):203-5. PubMed ID: 3298085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
    Felmingham D; Wall RA
    Drugs Exp Clin Res; 1985; 11(7):427-9. PubMed ID: 3939218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
    Robbins MJ; Marais R; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1987; 13(9):551-4. PubMed ID: 2962846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
    Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How and why aztreonam works.
    Rittenbury MS
    Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of aztreonam and other antimicrobial agents against Salmonella species.
    Paradelis AG; Delidou K; Stavrakis AO; Crassaris LG
    Drugs Exp Clin Res; 1985; 11(3):163-7. PubMed ID: 3836124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.
    Schell RF; Francisco M; Bihl JA; LeFrock JL
    Chemotherapy; 1985; 31(3):181-90. PubMed ID: 3888543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemobiotic sensitivity of common Gram-negative bacteria in urinary tract infections, 1981-1982].
    Mastandrea P; Delli Carri P
    Quad Sclavo Diagn; 1983 Dec; 19(4):455-62. PubMed ID: 6377362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.